Literature DB >> 34619717

Association Between Adverse Childhood Experiences and Adverse Pregnancy Outcomes.

Emily S Miller1, Oriana Fleming, Etoroabasi E Ekpe, William A Grobman, Nia Heard-Garris.   

Abstract

OBJECTIVE: To examine the association between adverse childhood experiences and adverse pregnancy outcomes.
METHODS: This cohort study included individuals who enrolled in a perinatal collaborative mental health care program (COMPASS [the Collaborative Care Model for Perinatal Depression Support Services]) between 2017 and 2021. Participants completed psychosocial self-assessments, including an adverse childhood experiences screen. The primary exposure was adverse childhood experiences measured by the ACE (adverse childhood experience) score, which was evaluated as a dichotomized variable, with a high ACE score defined as greater than three. Secondary analyses used the ACE score as a continuous variable. Adverse pregnancy outcomes including gestational diabetes, hypertensive disorders of pregnancy, preterm birth, and small-for-gestational-age (SGA) births were abstracted from the electronic health record. Bivariable and multivariable analyses were performed, including mediation analyses.
RESULTS: Of the 1,274 women with a completed adverse childhood experiences screen, 904 (71%) reported one or more adverse childhood experiences, and 290 (23%) reported a high ACE score (more than three adverse childhood experiences). Adverse childhood experience scores were not associated with gestational diabetes or SGA births. After controlling for potential confounders, individuals with high ACE score had 1.55-fold (95% CI 1.06-2.26) increased odds of having hypertensive disorders of pregnancy and 2.03-fold (95% CI 1.38-2.99) increased odds of preterm birth. Each point increase in ACE score was not associated with a statistically increased odds of hypertensive disorders of pregnancy (adjusted odds ratio [aOR] 1.07, 95% CI 0.99-1.15); however, each additional point on the adverse childhood experiences screen was associated with increased odds of preterm birth (aOR 1.13, 95% CI 1.05-1.22). Mediation analyses demonstrated tobacco use, chronic medical problems, and obesity each partially mediated the observed association between high ACE scores and hypertensive disorders of pregnancy. Having chronic medical comorbidities partially mediated the observed association between high ACE scores and preterm birth.
CONCLUSION: One in four individuals referred to a perinatal mental health program who were pregnant or postpartum had a high ACE score. Having a high ACE score was associated with an increased risk of hypertensive disorders of pregnancy and preterm birth. These results underscore how remote events may reverberate through the life course.
Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34619717      PMCID: PMC8542582          DOI: 10.1097/AOG.0000000000004570

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  38 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

2.  The occurrence of preterm delivery is linked to pregnancy-specific distress and elevated inflammatory markers across gestation.

Authors:  Mary E Coussons-Read; Marci Lobel; J Chris Carey; Marianne O Kreither; Kimberly D'Anna; Laura Argys; Randall G Ross; Chandra Brandt; Stephanie Cole
Journal:  Brain Behav Immun       Date:  2012-03-07       Impact factor: 7.217

3.  Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222.

Authors: 
Journal:  Obstet Gynecol       Date:  2020-06       Impact factor: 7.661

4.  Criteria for screening tests for gestational diabetes.

Authors:  M W Carpenter; D R Coustan
Journal:  Am J Obstet Gynecol       Date:  1982-12-01       Impact factor: 8.661

5.  The Role of Childhood Adversity in the Development of Gestational Diabetes.

Authors:  Danielle A J M Schoenaker; Leonie K Callaway; Gita D Mishra
Journal:  Am J Prev Med       Date:  2019-07-25       Impact factor: 5.043

6.  Role of oxidative stress and antioxidant supplementation in pregnancy disorders.

Authors:  Lucilla Poston; Natalia Igosheva; Hiten D Mistry; Paul T Seed; Andrew H Shennan; Sarosh Rana; S Ananth Karumanchi; Lucy C Chappell
Journal:  Am J Clin Nutr       Date:  2011-05-25       Impact factor: 7.045

7.  A standard of fetal growth for the United States of America.

Authors:  W E Brenner; D A Edelman; C H Hendricks
Journal:  Am J Obstet Gynecol       Date:  1976-11-01       Impact factor: 8.661

8.  Adverse childhood experiences and lifetime adverse maternal outcomes (gestational diabetes and hypertensive disorders of pregnancy) in the Hispanic Community Health Study/Study of Latinos.

Authors:  Kaitlyn K Stanhope; Alison L Cammack; Krista M Perreira; Lindsay Fernández-Rhodes; Christina Cordero; Linda C Gallo; Carmen R Isasi; Sheila F Castañeda; Martha L Daviglus; Michelle A Kominiarek; Shakira F Suglia
Journal:  Ann Epidemiol       Date:  2020-08-11       Impact factor: 3.797

9.  Vital Signs: Estimated Proportion of Adult Health Problems Attributable to Adverse Childhood Experiences and Implications for Prevention - 25 States, 2015-2017.

Authors:  Melissa T Merrick; Derek C Ford; Katie A Ports; Angie S Guinn; Jieru Chen; Joanne Klevens; Marilyn Metzler; Christopher M Jones; Thomas R Simon; Valerie M Daniel; Phyllis Ottley; James A Mercy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-11-08       Impact factor: 17.586

10.  Adverse childhood experiences and poor birth outcomes in a diverse, low-income sample.

Authors:  Joshua P Mersky; ChienTi Plummer Lee
Journal:  BMC Pregnancy Childbirth       Date:  2019-10-28       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.